Showing results (531-540 of 622) with videos related to

Sort By:
Pageof 63
Circulation|January 7, 2004
Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistanceWei C Lau, Paul A Gurbel, Paul B Watkins, et al.
Journal of Comparative Effectiveness Research|October 30, 2012
Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approachGregory Klein, Laura S Gold, Sean D Sullivan, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Design, implementation, and first-year outcomes of a value-based drug formularySean D Sullivan, Kai Yeung, Carol Vogeler, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 25, 2017
Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross ApproachMerrie Mosedale, Yunjung Kim, William J Brock, et al.
The American Journal of Gastroenterology|September 9, 2015
Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injuryRobert J Fontana, Paul H Hayashi, Huiman Barnhart, et al.
Frontiers in Allergy|August 17, 2023
Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical centerShawnalyn W Sunagawa, Scott J Bergman, Emily Kreikemeier, et al.
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Drug Safety|July 20, 2015
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B Watkins, James H Lewis, Neil Kaplowitz, et al.
Frontiers in Physiology|December 19, 2012
Modeling drug- and chemical-induced hepatotoxicity with systems biology approachesSudin Bhattacharya, Lisl K M Shoda, Qiang Zhang, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Pageof 63